Document is current
Any future updates will be listed below
-
Authors
Palassin, Pascale https://orcid.org/0000-0003-2717-9437
Maria, Alexandre T. J.
Ladhari, Chayma
Quantin, Xavier
Montani, David
Bourdin, Arnaud
Boissin, Clément
Fesler, Pierre
Hillaire-Buys, Dominique
Guilpain, Philippe
Faillie, Jean-Luc
- License Information
-
More Information
Article History
Received: 21 May 2021
Accepted: 8 April 2022
First Online: 26 May 2022
Declarations
:
: ATJM has received fees from Actelion and declares speaking fees from Astra-Zeneca, Sanofi-Aventis and BMS in the last 3 years. PG is a medical expert for LFB (Laboratoire Français du Biofractionnement) and has received fees from Abbvie, Actelion, Boehringer Ingelheim France, Bouchara-Recordati, Novartis, Pfizer, and Roche in the last 5 years. DM reports grants and personal fees from Actelion, grants and personal fees from Bayer, personal fees from GSK, personal fees from Pfizer, grants, personal fees and non-financial support from MSD, personal fees from Chiesi, personal fees from Boerhinger, non-financial support from Acceleron, outside the submitted work. PF has received travel and accommodation fees from Actelion, Johnson and Johnson, BMS, Pfizer and Servier in the last 5 years. Other authors declare that they have no conflicts of interest.
